Cargando…
Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial
OBJECTIVE: To evaluate a new levonorgestrel-releasing intrauterine system (LNG-IUS) called Levosert(®) for the treatment of heavy menstrual bleeding (HMB) in comparison to the reference product Mirena(®). METHODS: A multicentre, randomised, controlled trial, in non-menopausal women diagnosed with fu...
Autores principales: | Mawet, Marie, Nollevaux, Fabrice, Nizet, Dominique, Wijzen, Fabienne, Gordenne, Valérie, Tasev, Niso, Segedi, Dimitrije, Marinescu, Bogdan, Enache, Andreea, Parhomenko, Vadim, Frankenne, Francis, Foidart, Jean-Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133966/ https://www.ncbi.nlm.nih.gov/pubmed/24666176 http://dx.doi.org/10.3109/13625187.2014.894184 |
Ejemplares similares
-
Levonorgestrel intrauterine system: Current role in management of heavy menstrual bleeding
por: Magon, Navneet, et al.
Publicado: (2013) -
Development of an animal experimental model to study the effects of levonorgestrel on the human endometrium
por: Alvarez Gonzalez, M.-L., et al.
Publicado: (2009) -
Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device
por: Creinin, Mitchell D., et al.
Publicado: (2023) -
Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding
por: Beelen, Pleun, et al.
Publicado: (2021) -
Effect of modified levonorgestrel‐releasing intrauterine system in human adenomyosis with heavy menstrual bleeding
por: Yang, Hong, et al.
Publicado: (2021)